URL has been copied successfully!
‘Partnership’ on drug pricing also gives patients in Britain greater access to potentially life-extending treatments
British drug exports to the US will escape tariffs imposed by Donald Trump as part of a controversial UK-US medicines deal that critics fear will mean less money for the NHS.
The deal will also give patients in Britain greater access to potentially life-extending drugs because the rules have been relaxed to allow the NHS to pay more for particular treatments.
Please follow us:
This post was originally published here